New potential cell source for hepatocyte transplantation: Discarded livers from metabolic disease liver transplants

Stem Cell Research

Volumn 11, Issue 1, 2013, Pages 563-573

  Gramignoli, Roberto ^a   Tahan, Veysel ^b   Dorko, Kenneth ^b   Skvorak, Kristen J ^b   Hansel, Marc C ^b   Zhao, Wenchen ^b   Venkataramanan, Raman ^c   Ellis, Ewa C S ^d   Jorns, Carl ^d   Ericzon, Bo Goran ^d   Rosenborg, Staffan ^d   Kuiper, Raoul ^a   Soltys, Kyle A ^e   Mazariegos, George V ^e   Fox, Ira J ^e   Wilson, Elizabeth M ^f   Grompe, Markus ^g   Strom, Stephen C ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^e CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^f Yecuris Corporation   (United States)

^g OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 2C9; CYTOCHROME P450 3A4; CYTOCHROME P450 3A7;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL FUNCTION; CELL METABOLISM; CELL VIABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HEPATOCYTE TRANSPLANTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER DISEASE; MALE; METABOLIC DISORDER; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ADOLESCENT; ADULT; ANIMALS; CHILD; CHILD, PRESCHOOL; FEMALE; HEPATOCYTES; HUMANS; INFANT; LIVER; LIVER DISEASES; LIVER TRANSPLANTATION; MALE; MICE; YOUNG ADULT;

EID: 84877314691     PISSN: 18735061     EISSN: 18767753     Source Type: Journal    
DOI: 10.1016/j.scr.2013.03.002     Document Type: Article

References (27)

1. Azuma H., Paulk N., Ranade A., Dorrell C., Al-Dhalimy M., Ellis E., Strom S., et al. Robust expansion of human hepatocytes in Fah-/-/Rag2-/-/Il2rg-/- mice. Nat. Biotechnol. 2007, 25:903-910.
2. Bhogal R.H., Hodson J., Bartlett D.C., Weston C.J., Curbishley S.M., Haughton E., Williams K.T., et al. Isolation of primary human hepatocytes from normal and diseased liver tissue: a one hundred liver experience. PLoS One 2011, 6:e18222.
3. Dhawan A., Mitry R.R., Hughes R.D. Hepatocyte transplantation for liver-based metabolic disorders. J. Inherit. Metab. Dis. 2006, 29:431-435.
4. Donato M.T., Lahoz A., Jimenez N., Perez G., Serralta A., Mir J., Castell J.V., et al. Potential impact of steatosis on cytochrome P450 enzymes of human hepatocytes isolated from fatty liver grafts. Drug Metab. Dispos. 2006, 34:1556-1562.
5. Ericzon B.G., Larsson M., Wilczek H.E. Domino liver transplantation: risks and benefits. Transplant. Proc. 2008, 40:1130-1131.
6. Fisher R.A., Strom S.C. Human hepatocyte transplantation: worldwide results. Transplantation 2006, 82:441-449.
7. Fisher R.A., Bu D., Thompson M., Tisnado J., Prasad U., Sterling R., Posner M., et al. Defining hepatocellular chimerism in a liver failure patient bridged with hepatocyte infusion. Transplantation 2000, 69:303-307.
8. Fox I.J., Chowdhury J.R., Kaufman S.S., Goertzen T.C., Chowdhury N.R., Warkentin P.I., Dorko K., et al. Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation. N. Engl. J. Med. 1998, 338:1422-1426.
9. Gramignoli R., Green M., Tahan V., Dorko K., Skvorak K.J., Marongiu F., Zao W., et al. Development and application of purified dissociation enzyme mixtures for human hepatocyte isolation. Cell Transplant. 2012, 21:1245-1260.
10. Hines R.N., McCarver D.G. The ontogeny of human drug-metabolizing enzymes: phase I oxidative enzymes. J. Pharmacol. Exp. Ther. 2002, 300:355-360.
11. Horslen S.P., McCowan T.C., Goertzen T.C., Warkentin P.I., Cai H.B., Strom S.C., Fox I.J. Isolated hepatocyte transplantation in an infant with a severe urea cycle disorder. Pediatrics 2003, 111:1262-1267.
12. Hughes R.D., Mitry R.R., Dhawan A., Lehec S.C., Girlanda R., Rela M., Heaton N.D., et al. Isolation of hepatocytes from livers from non-heart-beating donors for cell transplantation. Liver Transpl. 2006, 12:713-717.
13. Kostrubsky V.E., Ramachandran V., Venkataramanan R., Dorko K., Esplen J.E., Zhang S., Sinclair J.F., et al. The use of human hepatocyte cultures to study the induction of cytochrome P-450. Drug Metab. Dispos. 1999, 27:887-894.
14. Lee K.W., Lee J.H., Shin S.W., Kim S.J., Joh J.W., Lee D.H., Kim J.W., et al. Hepatocyte transplantation for glycogen storage disease type Ib. Cell Transplant. 2007, 16:629-637.
15. Mazariegos G.V., Morton D.H., Sindhi R., Soltys K., Nayyar N., Bond G., Shellmer D., et al. Liver transplantation for classical maple syrup urine disease: long-term follow-up in 37 patients and comparative united network for organ sharing experience. J. Pediatr. 2012, 160:116-121. (e111).
16. Meyburg J., Alexandrova K., Barthold M., Kafert-Kasting S., Schneider A.S., Attaran M., Hoerster F., et al. Liver cell transplantation: basic investigations for safe application in infants and small children. Cell Transplant. 2009, 18:777-786.
17. Meyburg J., Das A.M., Hoerster F., Lindner M., Kriegbaum H., Engelmann G., Schmidt J., et al. One liver for four children: first clinical series of liver cell transplantation for severe neonatal urea cycle defects. Transplantation 2009, 87:636-641.
18. Mitry R.R., Dhawan A., Hughes R.D., Bansal S., Lehec S., Terry C., Heaton N.D., et al. One liver, three recipients: segment IV from split-liver procedures as a source of hepatocytes for cell transplantation. Transplantation 2004, 77:1614-1616.
19. Muraca M., Gerunda G., Neri D., Vilei M.T., Granato A., Feltracco P., Meroni M., et al. Hepatocyte transplantation as a treatment for glycogen storage disease type 1a. Lancet 2002, 359:317-318.
20. Popescu I., Dima S.O. Domino liver transplantation: how far can we push the paradigm?. Liver Transpl. 2012, 18:22-28.
21. Roels L., Rahmel A. The European experience. Transpl. Int. 2011, 24:350-367.
22. Stephenne X., Najimi M., Sibille C., Nassogne M.C., Smets F., Sokal E.M. Sustained engraftment and tissue enzyme activity after liver cell transplantation for argininosuccinate lyase deficiency. Gastroenterology 2006, 130:1317-1323.
23. Stephenne X., Debray F.G., Smets F., Jazouli N., Sana G., Trondreau T., Menten R., Goffette P., Boemer F., Schoos R., Gersting S.W., Najimi M., Muntau A.C., Goyens P., Sokal E.M. Hepatocyte transplantation using the domino concept on a child with tetrabiopterin nonresponsive phenylketonuria. Cell Transplant. 2012, 21:2765-2770.
24. Strom S.C., Fisher R.A., Thompson M.T., Sanyal A.J., Cole P.E., Ham J.M., Posner M.P. Hepatocyte transplantation as a bridge to orthotopic liver transplantation in terminal liver failure. Transplantation 1997, 63:559-569.
25. Strom S., Bruzzone P., Cai H., Ellis E., Lehmann T., Mitamura K., Miki T. Hepatocyte transplantation: clinical experience and potential for future use. Cell Transplant. 2006, 15:S105-S110.
26. Tolando R., Rose T., Moeller T.A. Selective Conjugation of 7-Hydroxycoumarin by Recombinant Human Uridine-5'-Diphospho-Glucuronosyltransferase (UGT) http://www.celsisivt.com/the-cryo-advantage/32-our-company/ivt-resources/88-ivt-publications-and-posters.
27. Wilczek H.E., Larsson M., Yamamoto S., Ericzon B.G. Domino liver transplantation. J. Hepatobiliary Pancreat. Surg. 2008, 15:139-148.